Therapeutic potential of histamine H4 receptor agonists in triple-negative human breast cancer experimental model

The presence of the histamine H₄ receptor (H₄R) was previously reported in benign and malignant lesions and cell lines derived from the human mammary gland. The aim of this work was to evaluate the effects of H₄R ligands on the survival, tumour growth rate and metastatic capacity of breast cancer in an experimental model.

Palabras clave: Histamine , Breast Cancer , H4 Receptor Ligands , Cell Proliferation , Apoptosis , Clozapine , Jnj28610244

Ver el registro completo

Archivos asociados

Tamaño: 1.642Mb

Formato: PDF

Descargar

Licencia

Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)

Identificadores

URI: http://hdl.handle.net/11336/1725

URL: http://onlinelibrary.wiley.com/doi/10.1111/bph.12137/epdf

URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764860/

DOI: http://dx.doi.org/DOI:10.1111/bph.12137

Colecciones

Articulos(OCA HOUSSAY)
Articulos de OFICINA DE COORDINACION ADMINISTRATIVA HOUSSAY

Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL

Citación

Martinel Lamas, Diego José; Croci, Máximo; Carabajal, Eliana; Crescenti, Ernesto J. V.; Sambuco, Lorena Andrea; et al.; Therapeutic potential of histamine H4 receptor agonists in triple-negative human breast cancer experimental model; Wiley; British Journal of Pharmacology; 170; 1; 9-2013; 188-199

Altmétricas